Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
August 28, 2018 - The FDA announced the permanent discontinuation of AstraZeneca’s Lynparza (olaparib) 50 mg capsules.
Return to publications